Skip to main content
Transactions of the American Ophthalmological Society logoLink to Transactions of the American Ophthalmological Society
. 1980;78:896–946.

Clinical research methodology in ophthalmology.

M I Kaiser-Kupfer
PMCID: PMC1312162  PMID: 7257074

Full text

PDF
896

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. AST D. B., SMITH D. J., WACHS B., CANTWELL K. T. Newburgh-Kingston caries-fluorine study. XIV. Combined clinical and roentgenographic dental findings after ten years of fluoride experience. J Am Dent Assoc. 1956 Mar;52(3):314–325. doi: 10.14219/jada.archive.1956.0042. [DOI] [PubMed] [Google Scholar]
  2. Ballintine E. J. Randomized controlled clinical trial. National Eye Institute workshop for ophthalmologists. Objective measurements and the double-masked procedure. Am J Ophthalmol. 1975 May;79(5):763–767. doi: 10.1016/0002-9394(75)90734-5. [DOI] [PubMed] [Google Scholar]
  3. Bearman J. E. Randomized controlled clinical trial. National Eye Institute workshop for ophthalmologists. Writing the protocol for a clinical trial. Am J Ophthalmol. 1975 May;79(5):775–778. doi: 10.1016/0002-9394(75)90736-9. [DOI] [PubMed] [Google Scholar]
  4. Byar D. P., Simon R. M., Friedewald W. T., Schlesselman J. J., DeMets D. L., Ellenberg J. H., Gail M. H., Ware J. H. Randomized clinical trials. Perspectives on some recent ideas. N Engl J Med. 1976 Jul 8;295(2):74–80. doi: 10.1056/NEJM197607082950204. [DOI] [PubMed] [Google Scholar]
  5. Chalmers T. C. Randomized controlled clinical trial. National Eye Institute workshop for ophthalmologists. Ethical aspects of clinical trials. Am J Ophthalmol. 1975 May;79(5):753–758. [PubMed] [Google Scholar]
  6. Cole M. P., Jones C. T., Todd I. D. A new anti-oestrogenic agent in late breast cancer. An early clinical appraisal of ICI46474. Br J Cancer. 1971 Jun;25(2):270–275. doi: 10.1038/bjc.1971.33. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. DOLL R., HILL A. B. MORTALITY IN RELATION TO SMOKING: TEN YEARS' OBSERVATIONS OF BRITISH DOCTORS. Br Med J. 1964 May 30;1(5395):1399–1410. doi: 10.1136/bmj.1.5395.1399. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Davis M. D., Hiller R., Magli Y. L., Podgor M. J., Ederer F., Harris W. A., Long J. W., Haug G. A. Prognosis for life in patients with diabetes: relation to severity of retinopathy. Trans Am Ophthalmol Soc. 1979;77:144–170. [PMC free article] [PubMed] [Google Scholar]
  9. Davis M. D. Randomized controlled clinical trial. National Eye Institute workshop for ophthalmologists. Application of the principles of clinical trials. Am J Ophthalmol. 1975 May;79(5):779–789. doi: 10.1016/0002-9394(75)90737-0. [DOI] [PubMed] [Google Scholar]
  10. Ederer F., Ferris F. L. Studying the role of an environmental factor in disease etiology. Am J Ophthalmol. 1979 Mar;87(3):434–435. doi: 10.1016/0002-9394(79)90099-0. [DOI] [PubMed] [Google Scholar]
  11. Ederer F. Patient bias, investigator bias and the double-masked procedure in clinical trials. Am J Med. 1975 Mar;58(3):295–299. doi: 10.1016/0002-9343(75)90594-x. [DOI] [PubMed] [Google Scholar]
  12. Ederer F. The randomized controlled clinical trial. National Eye Institute workshop for ophthalmologists. Foreword. Am J Ophthalmol. 1975 May;79(5):752–752. doi: 10.1016/0002-9394(75)90731-x. [DOI] [PubMed] [Google Scholar]
  13. Fredrickson D. S. The field trial: some thoughts on the indispensable ordeal. Bull N Y Acad Med. 1968 Aug;44(8):985–993. [PMC free article] [PubMed] [Google Scholar]
  14. Grace N. D., Muench H., Chalmers T. C. The present status of shunts for portal hypertension in cirrhosis. Gastroenterology. 1966 May;50(5):684–691. [PubMed] [Google Scholar]
  15. Heuson J. C. Current overview of EORTC clinical trials with tamoxifen. Cancer Treat Rep. 1976 Oct;60(10):1463–1466. [PubMed] [Google Scholar]
  16. Horwitz R. I., Feinstein A. R. Methodologic standards and contradictory results in case-control research. Am J Med. 1979 Apr;66(4):556–564. doi: 10.1016/0002-9343(79)91164-1. [DOI] [PubMed] [Google Scholar]
  17. Kahn H. A., Leibowitz H., Ganley J. P., Kini M., Colton T., Nickerson R., Dawber T. R. Randomized controlled clinical trial. National Eye Institute workshop for ophthalmologists. Standardizing diagnostic procedures. Am J Ophthalmol. 1975 May;79(5):768–775. [PubMed] [Google Scholar]
  18. Kahn H. A. The prevalence of chronic simple glaucoma in the United States. Am J Ophthalmol. 1972 Aug;74(2):355–359. doi: 10.1016/0002-9394(72)90565-x. [DOI] [PubMed] [Google Scholar]
  19. Kannel W. B., Castelli W. P., McNamara P. M. The coronary profile: 12-year follow-up in the Framingham study. J Occup Med. 1967 Dec;9(12):611–619. [PubMed] [Google Scholar]
  20. Kennaway N. G., Weleber R. G., Buist N. R. Gyrate atrophy of choroid and retina: deficient activity of ornithine ketoacid aminotransferase in cultured skin fibroblasts. N Engl J Med. 1977 Nov 24;297(21):1180–1180. doi: 10.1056/nejm197711242972116. [DOI] [PubMed] [Google Scholar]
  21. Kupfer C. Cooperative clinical trials. The Second Ticho Memorial Lecture. Am J Ophthalmol. 1975 Apr;79(4):543–548. [PubMed] [Google Scholar]
  22. Kupfer C., Kuwabara T., Kaiser-Kupfer M. The histopathology of pigmentary dispersion syndrome with glaucoma. Am J Ophthalmol. 1975 Nov;80(5):857–862. doi: 10.1016/0002-9394(75)90283-4. [DOI] [PubMed] [Google Scholar]
  23. Legha S. S., Carter S. K. Antiestrogens in the treatment of breast cancer. Cancer Treat Rev. 1976 Dec;3(4):205–216. doi: 10.1016/s0305-7372(76)80010-2. [DOI] [PubMed] [Google Scholar]
  24. O'Donnell J. J., Sandman R. P., Martin S. R. Deficient L-ornithine: 2-oxoacid aminotransferase activity in cultured fibroblasts from a patient with gyrate atrophy of the retina. Biochem Biophys Res Commun. 1977 Nov 21;79(2):396–399. doi: 10.1016/0006-291x(77)90170-x. [DOI] [PubMed] [Google Scholar]
  25. Rand L., Kupfer C. Clinical trials in diabetic retinopathy. Int Ophthalmol Clin. 1978 Winter;18(4):17–34. [PubMed] [Google Scholar]
  26. Ruffin J. M., Grizzle J. E., Hightower N. C., McHardy G., Shull H., Kirsner J. B. A co-operative double-blind evaluation of gastric "freezing" in the treatment of duodenal ulcer. N Engl J Med. 1969 Jul 3;281(1):16–19. doi: 10.1056/NEJM196907032810104. [DOI] [PubMed] [Google Scholar]
  27. SHAPIRO S., WEINBLATT E., FRANK C. W., SAGER R. V., DENSEN P. M. THE H.I.P. STUDY OF INCIDENCE AND PROGNOSIS OF CORONARY HEART DISEASE: METHODOLOGY. J Chronic Dis. 1963 Dec;16:1281–1292. doi: 10.1016/0021-9681(63)90069-9. [DOI] [PubMed] [Google Scholar]
  28. Sartwell P. E., Masi A. T., Arthes F. G., Greene G. R., Smith H. E. Thromboembolism and oral contraceptives: an epidemiologic case-control study. Am J Epidemiol. 1969 Nov;90(5):365–380. doi: 10.1093/oxfordjournals.aje.a121082. [DOI] [PubMed] [Google Scholar]
  29. Sartwell P. E. Retrospective studies. A review for the clinician. Ann Intern Med. 1974 Sep;81(3):381–386. doi: 10.7326/0003-4819-81-3-381. [DOI] [PubMed] [Google Scholar]
  30. Seashore M. R., Durant J. L., Rosenberg L. E. Studies of the mechanism of pyridoxine-responsive homocystinuria. Pediatr Res. 1972 Mar;6(3):187–196. doi: 10.1203/00006450-197203000-00007. [DOI] [PubMed] [Google Scholar]
  31. Seigel D. G., Loncin H. A critique of studies of long-term survivorship of patients with a myocardial infarction. Am J Public Health Nations Health. 1968 Aug;58(8):1348–1354. doi: 10.2105/ajph.58.8.1348. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Shaw L. W., Chalmers T. C. Ethics in cooperative clinical trials. Ann N Y Acad Sci. 1970 Jan 21;169(2):487–495. doi: 10.1111/j.1749-6632.1970.tb54759.x. [DOI] [PubMed] [Google Scholar]
  33. Shih V. E., Berson E. L., Mandell R., Schmidt S. Y. Ornithine ketoacid transaminase deficiency in gyrate atrophy of the choroid and retina. Am J Hum Genet. 1978 Mar;30(2):174–179. [PMC free article] [PubMed] [Google Scholar]
  34. Silverman W. A. The lesson of retrolental fibroplasia. Sci Am. 1977 Jun;236(6):100–107. doi: 10.1038/scientificamerican0677-100. [DOI] [PubMed] [Google Scholar]
  35. Simell O., Takki K. Raised plasma-ornithine and gyrate atrophy of the choroid and retina. Lancet. 1973 May 12;1(7811):1031–1033. doi: 10.1016/s0140-6736(73)90667-3. [DOI] [PubMed] [Google Scholar]
  36. Tormey D. C., Simon R. M., Lippman M. E., Bull J. M., Myers C. E. Evaluation of tamoxifen dose in advanced breast cancer: a progress report. Cancer Treat Rep. 1976 Oct;60(10):1451–1459. [PubMed] [Google Scholar]
  37. Trijbels J. M., Sengers R. C., Bakkeren J. A., De Kort A. F., Deutman A. F. L-Ornithine-ketoacid-transaminase deficiency in cultured fibroblasts of a patient with hyperornithinaemia and gyrate atrophy of the choroid and retina. Clin Chim Acta. 1977 Sep 1;79(2):371–377. doi: 10.1016/0009-8981(77)90431-4. [DOI] [PubMed] [Google Scholar]
  38. Valle D., Kaiser-Kupfer M. I., Del Valle L. A. Gyrate atrophy of the choroid and retina: deficiency of ornithine aminotransferase in transformed lymphocytes. Proc Natl Acad Sci U S A. 1977 Nov;74(11):5159–5161. doi: 10.1073/pnas.74.11.5159. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Viladiu P., Bosch F. X., Benito E., Alonso M. C. Antiestrogen tamoxifen in the treatment of advanced breast cancer: a series of 31 patients. Cancer Treat Rep. 1977 Aug;61(5):899–900. [PubMed] [Google Scholar]
  40. Weleber R. G., Kennaway N. G., Buist N. R. Vitamin B6 in management of gyrate atrophy of choroid and retina. Lancet. 1978 Dec 2;2(8101):1213–1213. doi: 10.1016/s0140-6736(78)92211-0. [DOI] [PubMed] [Google Scholar]

Articles from Transactions of the American Ophthalmological Society are provided here courtesy of American Ophthalmological Society

RESOURCES